iBio, Inc. (IBIO)
NYSEAMERICAN: IBIO · IEX Real-Time Price · USD
2.150
+0.040 (1.90%)
At close: Jul 19, 2024, 12:00 AM
2.180
+0.030 (1.40%)
Pre-market: Jul 22, 2024, 8:48 AM EDT
iBio, Inc. Employees
iBio, Inc. had 26 employees as of June 30, 2023. The number of employees decreased by 80 or -75.47% compared to the previous year.
Employees
26
Change (1Y)
-80
Growth (1Y)
-75.47%
Revenue / Employee
$1,923
Profits / Employee
-$890,846
Market Cap
18.54M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
VBI Vaccines | 138 |
Lyra Therapeutics | 88 |
Aspira Women's Health | 64 |
Biotricity | 55 |
Sensei Biotherapeutics | 28 |
Microbot Medical | 22 |
Aeterna Zentaris | 12 |
Indaptus Therapeutics | 7 |
IBIO News
- 7 weeks ago - iBio Closes Sale of Manufacturing Facility in Texas - GlobeNewsWire
- 2 months ago - iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 months ago - iBio stock nearly tripled on Wednesday: here's why - Invezz
- 4 months ago - iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases - GlobeNewsWire
- 4 months ago - iBio Announces $15.0 Million Private Placement - GlobeNewsWire
- 5 months ago - iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka - GlobeNewsWire
- 6 months ago - iBio Announces Participation in 23rd Annual PepTalk Conference - GlobeNewsWire
- 6 months ago - Top 4 Health Care Stocks That May Rocket Higher In Q1 - AlloVir (NASDAQ:ALVR), GRI Bio (NASDAQ:GRI) - Benzinga